Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 16472

1.

Association between buprenorphine/naloxone and high-dose opioid analgesic prescribing in Kentucky, 2012-2017.

Luu H, Slavova S, Freeman PR, Lofwall M, Browning S, Slade E, Bush H.

Drug Alcohol Depend. 2019 Oct 3;205:107606. doi: 10.1016/j.drugalcdep.2019.107606. [Epub ahead of print]

PMID:
31606590
2.

Educational achievement at age 9.5 years of children born to mothers maintained on methadone during pregnancy.

Lee SJ, Woodward LJ, Henderson JMT.

PLoS One. 2019 Oct 10;14(10):e0223685. doi: 10.1371/journal.pone.0223685. eCollection 2019.

3.

Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis.

Premkumar A, Grobman WA, Terplan M, Miller ES.

Obstet Gynecol. 2019 Oct 8. doi: 10.1097/AOG.0000000000003503. [Epub ahead of print]

PMID:
31599845
4.

Comparison of the sedative effects of alfaxalone and methadone with or without midazolam in dogs.

Micieli F, Chiavaccini L, Paré MD, Chagas JB, Vesce G, Gianotti G.

Can Vet J. 2019 Oct;60(10):1060-1064.

PMID:
31597990
5.

Measuring relationships between proactive reporting state-level prescription drug monitoring programs and county-level fatal prescription opioid overdoses.

Cerdá M, Ponicki W, Smith N, Rivera-Aguirre A, Davis CS, Marshall BDL, Fink DS, Henry SG, Castillo-Carniglia A, Wintemute GJ, Gaidus A, Gruenewald P, Martins SS.

Epidemiology. 2019 Oct 7. doi: 10.1097/EDE.0000000000001123. [Epub ahead of print]

PMID:
31596794
6.

The place of methadone in the Game of the Goose for postoperative pain.

Garra R, Sbaraglia F.

Minerva Anestesiol. 2019 Oct;85(10):1041-1043. doi: 10.23736/S0375-9393.19.13939-9. No abstract available.

PMID:
31592624
7.

Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.

Bagley SM, Larochelle MR, Xuan Z, Wang N, Patel A, Bernson D, Silverstein M, Hadland SE, Land T, Samet JH, Walley AY.

Ann Emerg Med. 2019 Oct 4. pii: S0196-0644(19)30616-X. doi: 10.1016/j.annemergmed.2019.07.030. [Epub ahead of print]

PMID:
31591014
8.

Public policy, attitudes and willingness to pay for treatment of substance dependence in Iran.

Ahmadian Moghaddam S, Mazyaki A, Razaghi EM.

Int J Drug Policy. 2019 Oct 1;74:84-89. doi: 10.1016/j.drugpo.2019.08.005. [Epub ahead of print]

PMID:
31585318
9.

A possible solution to model nonlinearity in elimination and distributional clearances with α2 -adrenergic receptor agonists: Example of the intravenous detomidine and methadone combination in sedated horses.

Gozalo-Marcilla M, Moreira da Silva R, Pacca Loureiro Luna S, Rodrigues de Oliveira A, Werneck Fonseca M, Peporine Lopes N, Taylor PM, Pelligand L.

J Vet Pharmacol Ther. 2019 Oct 4. doi: 10.1111/jvp.12815. [Epub ahead of print]

PMID:
31584710
10.

The mobile-phone-based iCOTM Smokerlyzer®: Comparison with the piCO+ Smokerlyzer® among smokers undergoing methadone-maintained therapy.

Wong HY, Subramaniyan M, Bullen C, Amer Siddiq AN, Danaee M, Yee A.

Tob Induc Dis. 2019 Sep 9;17:65. doi: 10.18332/tid/111355. eCollection 2019.

11.

Preparation, Characterization and Dermal Delivery of Methadone.

Kung CP, Sil BC, Hadgraft J, Lane ME, Patel B, McCulloch R.

Pharmaceutics. 2019 Oct 2;11(10). pii: E509. doi: 10.3390/pharmaceutics11100509.

12.

Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health Records.

Hughey JJ, Colby JM.

Clin Chem. 2019 Oct 2. pii: clinchem.2019.305409. doi: 10.1373/clinchem.2019.305409. [Epub ahead of print]

PMID:
31578215
13.

The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015.

Walley AY, Bernson D, Larochelle MR, Green TC, Young L, Land T.

Public Health Rep. 2019 Oct 2:33354919878429. doi: 10.1177/0033354919878429. [Epub ahead of print]

PMID:
31577519
14.

Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia.

Jones NR, Shanahan M, Dobbins T, Degenhardt L, Montebello M, Gisev N, Larney S.

Drug Alcohol Rev. 2019 Sep;38(6):690-698. doi: 10.1111/dar.12976.

PMID:
31577058
15.

Relationship of County Opioid Epidemic Severity to Changes in Access to Substance Use Disorder Treatment, 2009-2017.

Yarbrough CR, Abraham AJ, Adams GB.

Psychiatr Serv. 2019 Oct 2:appips201900150. doi: 10.1176/appi.ps.201900150. [Epub ahead of print]

PMID:
31575353
16.

The Discrimination Against, Health Status and Wellness of People Who Use Drugs in Italian Services: A Survey.

Pelullo CP, Curcio F, Auriemma F, Cefalo G, Fabozzi A, Rossiello R, Spagnoli L, Attena F.

Medicina (Kaunas). 2019 Sep 30;55(10). pii: E662. doi: 10.3390/medicina55100662.

17.

Adjuvant laser meridian massage in men with opioid use disorder on methadone maintenance treatment: Protocol for a case-controlled study.

Hu WL, Tsai MC, Kuo CE, Liu CT, Wu SY, Wu TC, Hung YC.

Medicine (Baltimore). 2019 Sep;98(39):e17319. doi: 10.1097/MD.0000000000017319.

18.

Opioid Use Disorder: Medical Treatment Options.

Coffa D, Snyder H.

Am Fam Physician. 2019 Oct 1;100(7):416-425.

PMID:
31573166
19.

Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.

Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD.

Addict Sci Clin Pract. 2019 Oct 1;14(1):37. doi: 10.1186/s13722-019-0166-0.

20.

Salivary cortisol levels relate to cognitive performance in children prenatally exposed to methadone or buprenorphine.

Konijnenberg C, Melinder A.

Dev Psychobiol. 2019 Sep 28. doi: 10.1002/dev.21921. [Epub ahead of print]

PMID:
31564069

Supplemental Content

Loading ...
Support Center